These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12798332)

  • 1. Cyclic amine sulfonamides as linkers in the design and synthesis of novel human beta(3) adrenergic receptor agonists.
    Sum FW; Wong V; Han S; Largis E; Mulvey R; Tillett J
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2191-4. PubMed ID: 12798332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonists.
    Hu B; Ellingboe J; Han S; Largis E; Lim K; Malamas M; Mulvey R; Niu C; Oliphant A; Pelletier J; Singanallore T; Sum FW; Tillett J; Wong V
    Bioorg Med Chem; 2001 Aug; 9(8):2045-59. PubMed ID: 11504641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel substituted 4-aminomethylpiperidines as potent and selective human beta3-agonists. Part 1: aryloxypropanolaminomethylpiperidines.
    Steffan RJ; Ashwell MA; Solvibile WR; Matelan E; Largis E; Han S; Tillet J; Mulvey R
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2957-61. PubMed ID: 12270183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel substituted 4-aminomethylpiperidines as potent and selective human beta3-agonists. Part 2: arylethanolaminomethylpiperidines.
    Steffan RJ; Ashwell MA; Solvibile WR; Matelan E; Largis E; Han S; Tillet J; Mulvey R
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2963-7. PubMed ID: 12270184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists.
    Hu B; Ellingboe J; Han S; Largis E; Mulvey R; Oliphant A; Sum FW; Tillett J
    J Med Chem; 2001 Apr; 44(9):1456-66. PubMed ID: 11311069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.
    Harada H; Hirokawa Y; Suzuki K; Hiyama Y; Oue M; Kawashima H; Yoshida N; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1301-5. PubMed ID: 12657269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agents.
    Biftu T; Feng DD; Liang GB; Kuo H; Qian X; Naylor EM; Colandrea VJ; Candelore MR; Cascieri MA; Colwell LF; Forrest MJ; Hom GJ; MacIntyre DE; Stearns RA; Strader CD; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1431-4. PubMed ID: 10888325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptamine-based human beta3-adrenergic receptor agonists. Part 2: SAR of the methylene derivatives.
    Sawa M; Tateishi H; Mizuno K; Harada H; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5963-6. PubMed ID: 15546708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties.
    Brockunier LL; Candelore MR; Cascieri MA; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE; Parmee ER
    Bioorg Med Chem Lett; 2001 Feb; 11(3):379-82. PubMed ID: 11212115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptor.
    Weber AE; Mathvink RJ; Perkins L; Hutchins JE; Candelore MR; Tota L; Strader CD; Wyvratt MJ; Fisher MH
    Bioorg Med Chem Lett; 1998 May; 8(9):1101-6. PubMed ID: 9871716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent, selective 3-pyridylethanolamine beta3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore.
    Mathvink RJ; Tolman JS; Chitty D; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Sep; 10(17):1971-3. PubMed ID: 10987429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted oxazole benzenesulfonamides as potent human beta3 adrenergic receptor agonists.
    Ok HO; Reigle LB; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Strader CD; Tota L; Wang P; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1531-4. PubMed ID: 10915043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide.
    Mathvink RJ; Tolman JS; Chitty D; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Miller RR; Stearns RA; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    J Med Chem; 2000 Oct; 43(21):3832-6. PubMed ID: 11052788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres.
    Uehling DE; Donaldson KH; Deaton DN; Hyman CE; Sugg EE; Barrett DG; Hughes RG; Reitter B; Adkison KK; Lancaster ME; Lee F; Hart R; Paulik MA; Sherman BW; True T; Cowan C
    J Med Chem; 2002 Jan; 45(3):567-83. PubMed ID: 11806709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New oxadiazolidinedione derivatives as potent and selective human beta3 agonists.
    Hu B; Malamas M; Ellingboe J; Largis E; Han S; Mulvey R; Tillett J
    Bioorg Med Chem Lett; 2001 Apr; 11(8):981-4. PubMed ID: 11327605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist.
    Parmee ER; Ok HO; Candelore MR; Tota L; Deng L; Strader CD; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 1998 May; 8(9):1107-12. PubMed ID: 9871717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tertiary amine nitrogen atom of piperazine sulfonamides as a novel determinant of potent and selective beta3-adrenoceptor agonists.
    Perrone MG; Bleve L; Santandrea E; Vitale P; Niso M; Scilimati A
    ChemMedChem; 2009 Dec; 4(12):2080-97. PubMed ID: 19882697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent oxindole based human beta3 adrenergic receptor agonists.
    Stevens FC; Bloomquist WE; Borel AG; Cohen ML; Droste CA; Heiman ML; Kriauciunas A; Sall DJ; Tinsley FC; Jesudason CD
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6270-3. PubMed ID: 17911024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of 3D-QSAR models in cyclic ureidobenzenesulfonamides: human beta3-adrenergic receptor agonist.
    Kashaw SK; Rathi L; Mishra P; Saxena AK
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2481-4. PubMed ID: 12852947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel and potent human and rat beta3-adrenergic receptor agonist, [3-[(2R)-[[(2R)-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1H-indol-7-yloxy]acetic acid.
    Harada H; Hirokawa Y; Suzuki K; Hiyama Y; Oue M; Kawashima H; Kato H; Yoshida N; Furutani Y; Kato S
    Chem Pharm Bull (Tokyo); 2005 Feb; 53(2):184-98. PubMed ID: 15684518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.